Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Artículo | IMSEAR | ID: sea-200029

RESUMEN

Atrial fibrillation is associated with high risk of ischaemic stroke which is considered a major fatal complication in atrial fibrillation. That’s why, anticoagulants were used to prevent this major complication. However, anticoagulants themselves are associated with their own complications. A systematic search of Embase, Medline and Google scholar were conducted. The included papers were extracted for outcomes related to the complications of each drugs. A Bayesian network meta-analysis based on Markov chain Monte Carlo simulation (MCMC) with 10000 burn-in iterations and 50000 inference iterations. We found eighteen papers that fit our inclusion criteria. Apixaban had the least risk of major bleeding compared to Warfarin [HR = 0.536, 95% (0.448, 0.652)] and the least risk of gastrointestinal hemorrhage. For stroke risk, the Rivaroxaban had the least risk compared to Warfarin [HR = 1.05, 95% (0.98, 1.14)]. For intracranial hemorrhage, dabigatran had the least risk of intracranial haemorrhage compared to Warfarin [HR = 0.46, 95% CrI (0.36, 0.61)]. For the thromboembolism risk, other non-vitamin k antagonist had the least risk of intracranial haemorrhage compared to Warfarin [HR = 0.523, 95% (0.095, 2.85)]. There were no conclusive results about the best anticoagulant drugs for non-valvular atrial fibrillation. Apixaban was the least among them to be associated with major bleeding, while rivaroxaban was ranked the first with least stroke complications. Furthermore, dabigatran was associated with less risk of intracranial haemorrhage compared to other anticoagulants.

2.
Ann Card Anaesth ; 2010 May; 13(2): 102-109
Artículo en Inglés | IMSEAR | ID: sea-139510

RESUMEN

Non-valvular heart disease is an important cause of cardiac disease in pregnancy and presents a unique challenge to the anesthesiologist during labor and delivery. A keen understanding of the underlying pathophysiology, in addition to the altered physiology of pregnancy, is the key to managing such patients. Disease-specific goals of management may help preserve the hemodynamic and ventilatory parameters within an acceptable limit and a successful conduct of labor and postpartum period..


Asunto(s)
Anestesia General/métodos , Anestesia Obstétrica/métodos , Cardiomiopatías/fisiopatología , Cardiomiopatías/cirugía , Complejo de Eisenmenger/fisiopatología , Complejo de Eisenmenger/cirugía , Femenino , Cardiopatías Congénitas/fisiopatología , Cardiopatías Congénitas/cirugía , Cardiopatías/fisiopatología , Cardiopatías/cirugía , Humanos , Hipertensión Pulmonar/fisiopatología , Hipertensión Pulmonar/cirugía , Infarto del Miocardio/fisiopatología , Infarto del Miocardio/cirugía , Embarazo/fisiología , Complicaciones Cardiovasculares del Embarazo/fisiopatología , Complicaciones Cardiovasculares del Embarazo/cirugía , Tetralogía de Fallot/fisiopatología , Tetralogía de Fallot/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA